<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Januar 2023]]></title><description><![CDATA[<p dir="auto">2 Healthcare Stocks That Could Make You Richer</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.proinvestor.com/investornyt/924488/2-healthcare-stocks-that-could-make-you-richer">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.proinvestor.com/investornyt/924488/2-healthcare-stocks-that-could-make-you-richer" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.proinvestor.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.proinvestor.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400870/pharma-januar-2023</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 13:52:19 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400870.rss" rel="self" type="application/rss+xml"/><pubDate>Sun, 08 Jan 2023 14:32:00 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Januar 2023 on Tue, 31 Jan 2023 07:56:14 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck/Nordea: Kursmål sænkes før regnskab - stadig attraktiv aktie <a href="https://www.proinvestor.com/investornyt/933772/lundbeck-nordea-kursmal-saenkes-for-regnskab-stadig-attraktiv-aktie" rel="nofollow ugc">https://www.proinvestor.com/investornyt/933772/lundbeck-nordea-kursmal-saenkes-for-regnskab-stadig-attraktiv-aktie</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037652</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037652</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 31 Jan 2023 07:56:14 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Wed, 25 Jan 2023 10:20:27 GMT]]></title><description><![CDATA[<p dir="auto">3 Reasons Why Johnson &amp; Johnson Stock Could Rebound After a Bad Start in 2023 <a href="https://www.proinvestor.com/investornyt/931259/3-reasons-why-johnson-amp-johnson-stock-could-rebound-after-a-bad-start-in-2023" rel="nofollow ugc">https://www.proinvestor.com/investornyt/931259/3-reasons-why-johnson-amp-johnson-stock-could-rebound-after-a-bad-start-in-2023</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037649</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037649</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 25 Jan 2023 10:20:27 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Mon, 23 Jan 2023 05:00:52 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck/Citi: Indledes med "neutral" og kursmål på 30 kr <a href="https://www.proinvestor.com/investornyt/930139/lundbeck-citi-indledes-med-neutral-og-kursmal-pa-30-kr" rel="nofollow ugc">https://www.proinvestor.com/investornyt/930139/lundbeck-citi-indledes-med-neutral-og-kursmal-pa-30-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037647</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037647</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 23 Jan 2023 05:00:52 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Fri, 20 Jan 2023 13:54:16 GMT]]></title><description><![CDATA[<p dir="auto">2 Healthcare Stocks You Can Buy and Hold for the Next Decade <a href="https://www.proinvestor.com/investornyt/929618/2-healthcare-stocks-you-can-buy-and-hold-for-the-next-decade" rel="nofollow ugc">https://www.proinvestor.com/investornyt/929618/2-healthcare-stocks-you-can-buy-and-hold-for-the-next-decade</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037646</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037646</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 20 Jan 2023 13:54:16 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Fri, 13 Jan 2023 15:03:08 GMT]]></title><description><![CDATA[<p dir="auto">Kort video -Der har det sidste års tid været meget støj på aktiemarkederne med gisninger om, hvordan centralbankerne vil agere osv. Det har medvirket til et volatilt marked. Forude venter masser af regnskaber fra Q4 - og dét, sammen med guidings, er noget, Helge Larsen og andre langsigtede investorer for alvor kan bruge til noget, når han ser fremad. <a href="https://www.proinvestor.com/boards/109501/" rel="nofollow ugc">https://www.proinvestor.com/boards/109501/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037648</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037648</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 13 Jan 2023 15:03:08 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Fri, 13 Jan 2023 14:07:06 GMT]]></title><description><![CDATA[<p dir="auto">Kort video - Ambu ' Bavarian Nordic ' Hansa Biopharma ' Genmab ' Novo Nordisk ' Zealand Pharma ' Anavex</p>
<p dir="auto">Helge Larsen gennemgår det sidste nye om virksomhederne inden for pharma og biotek ud fra den kvalificerede debat og chat på Proinvestor. <a href="https://www.proinvestor.com/boards/109502/" rel="nofollow ugc">https://www.proinvestor.com/boards/109502/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037651</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037651</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 13 Jan 2023 14:07:06 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Thu, 12 Jan 2023 06:07:24 GMT]]></title><description><![CDATA[<p dir="auto">Roche: European Commission Approves Xofluza For Children Aged One Year And Above <a href="https://www.proinvestor.com/investornyt/926184/roche-european-commission-approves-xofluza-for-children-aged-one-year-and-above" rel="nofollow ugc">https://www.proinvestor.com/investornyt/926184/roche-european-commission-approves-xofluza-for-children-aged-one-year-and-above</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037643</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037643</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 12 Jan 2023 06:07:24 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Mon, 09 Jan 2023 12:56:21 GMT]]></title><description><![CDATA[<p dir="auto">Teva Pharma Confirms Participation From 48 States On Opioids Settlement <a href="https://www.proinvestor.com/investornyt/924699/teva-pharma-confirms-participation-from-48-" rel="nofollow ugc">https://www.proinvestor.com/investornyt/924699/teva-pharma-confirms-participation-from-48-</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037645</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037645</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 09 Jan 2023 12:56:21 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Mon, 09 Jan 2023 09:03:44 GMT]]></title><description><![CDATA[<p dir="auto">Analytiker: Forlomme til Lundbeck hos FDA er positiv men ventet<br />
<a href="https://www.proinvestor.com/investornyt/924580/analytiker-forlomme-til-lundbeck-hos-fda-er-positiv-men-ventet" rel="nofollow ugc">https://www.proinvestor.com/investornyt/924580/analytiker-forlomme-til-lundbeck-hos-fda-er-positiv-men-ventet</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037650</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037650</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 09 Jan 2023 09:03:44 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Mon, 09 Jan 2023 05:27:29 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037644</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037644</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 09 Jan 2023 05:27:29 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Januar 2023 on Mon, 09 Jan 2023 05:03:26 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får opprioteret Alzheimersmiddel i USA af FDA</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.proinvestor.com/investornyt/924546/lundbeck-far-opprioteret-alzheimersmiddel-i-usa-af-fda">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.proinvestor.com/investornyt/924546/lundbeck-far-opprioteret-alzheimersmiddel-i-usa-af-fda" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.proinvestor.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.proinvestor.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037653</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037653</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 09 Jan 2023 05:03:26 GMT</pubDate></item></channel></rss>